Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by EyePoint, Inc. (NASDAQ: EYPT) on behalf of investors who purchased or acquired EyePoint, Inc. securities and experienced significant financial losses.
EyePoint Reports Disappointing Phase 3 Clinical Trials
On August 17, 2026, EyePoint issued a press release “announc[ing] topline results from LUGANO, the first pivotal Phase 3 clinical trial for DURAVYU™ (vorolanib intravitreal insert) for the treatment of wet age-related macular degeneration (wet AMD).” Specifically, EyePoint disclosed that DURAVYU did not meet the prespecified primary endpoint — change in best-corrected visual acuity versus on-label aflibercept — in the full dataset of the company’s Phase 3 LUGANO trial in wet age-related macular degeneration.
EyePoint’s Stock Drops Over 66%
Following the news of EyePoint, Inc.’s poor clinical trial results, the company’s stock price fell over 66%.
Investors who purchased EyePoint, Inc. (NASDAQ: EYPT) securities and experienced losses may have legal rights under the federal securities laws.
CONTACT KTMC TO DISCUSS YOUR LEGAL RIGHTS:
If you purchased or acquired EyePoint, Inc. securities and have lost money on your investment, please provide your information here: https://www.ktmc.com/eypt-eyepoint-pharmaceuticals-investigation?utm_campaign=hc?utm_source=Businesswire&utm_medium=pressrelease&utm_campaign=eypt&mktm=PR
There is no cost or obligation to speak with an attorney.
ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP (KTMC):
Kessler Topaz Meltzer & Check, LLP (KTMC) is a leading U.S. plaintiff-side law firm focused on securities-fraud class actions and global investor protection. The firm represents individual investors as well as institutions, such as major pension funds, asset managers, and international investors. KTMC has led some of the largest recoveries in securities litigation and has been recognized by peers and the legal media with numerous accolades, including being recognized in Chambers & Partners USA 2026 as a Band 1 Top Firm in Securities and Class Actions, Legal 500’s Tier 1 Rankings for Securities and M&A Litigation, The National Law Journal’s Plaintiff’s Hot List and Trailblazers in Plaintiffs’ Law, BTI Consulting Group’s Honor Roll of Most Feared Law Firms, The Legal Intelligencer’s Class Action Firm of the Year, Lawdragon’s Leading Plaintiff Financial Lawyers, and Law360’s Titans of the Plaintiffs Bar. The firm operates globally with offices in Pennsylvania and California. KTMC has recovered over $25 billion for our clients and the classes they represent.
May be considered attorney advertising in certain jurisdictions. Past results do not guarantee future outcomes.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260826189062/en/
Media gallery
